| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |